Benchmark and data visualization of Swedish public listed companies in the Biotechnology Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Sweden public listed companies in the Biotechnology industry: 18
Sweden Biotechnology total companies market cap (USD): $8.08 Billion
Company | Market Cap (USD) | Country | Sector | Industry |
---|---|---|---|---|
Camurus AB | $3.30 B |
![]() |
![]() |
![]() |
BioArctic AB | $1.84 B |
![]() |
![]() |
![]() |
Calliditas Therapeutics AB | $1.04 B |
![]() |
![]() |
![]() |
Hansa Biopharma AB | $319.2 M |
![]() |
![]() |
![]() |
Xspray Pharma AB | $252.9 M |
![]() |
![]() |
![]() |
BioInvent International AB |
$252.5 M
(July 1, 2025) |
![]() |
![]() |
![]() |
Vicore Pharma Holding AB | $201.1 M |
![]() |
![]() |
![]() |
Genovis AB |
$199.4 M
(July 1, 2025) |
![]() |
![]() |
![]() |
Egetis Therapeutics AB |
$175.8 M
(July 1, 2025) |
![]() |
![]() |
![]() |
Diamyd Medical AB | $126.1 M |
![]() |
![]() |
![]() |